MENU
PILL
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

PILL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
PILL
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for PILL with price predictions
Oct 14, 2026

PILL in downward trend: price dove below 50-day moving average on September 09, 2026

PILL moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend. In 36 of 38 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for PILL crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PILL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PILL entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +8.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where PILL advanced for three days, in 295 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

PILL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF is 50.62B. The market cap for tickers in the group ranges from 285.36M to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is EYPT at 285.36M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF was 25%. For the same ETF, the average monthly price growth was 51%, and the average quarterly price growth was 148%. PCRX experienced the highest price growth at 44%, while CTNM experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF was 22%. For the same stocks of the ETF, the average monthly volume growth was 39% and the average quarterly volume growth was -12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 58
Price Growth Rating: 53
SMR Rating: 73
Profit Risk Rating: 71
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
PILL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
PILL in downward trend: price dove below 50-day moving average on September 09, 2026